Free Trial
CVE:EMH

Emerald Health Therapeutics (EMH) Stock Price, News & Analysis

C$0.26
-0.01 (-3.77%)
(As of 04/26/2021)
Today's Range
C$0.25
C$0.27
50-Day Range
C$0.26
C$0.26
52-Week Range
C$0.15
C$0.53
Volume
384,329 shs
Average Volume
644,760 shs
Market Capitalization
C$52.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EMH stock logo

About Emerald Health Therapeutics Stock (CVE:EMH)

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

EMH Stock Price History

EMH Stock News Headlines

Emerald Princess
University Hospitals Elyria Medical Center
Emerald Care Center Tulsa
Emerald Reeg
Emerald Health Therapeutics Inc (TBD.BE)
Emperor Oil Ltd (EMh)
Stocks in play: Emerald Health Therapeutics Inc
Emerald Health Therapeutics Reports 2021 AGM Results
See More Headlines
Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
161
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$13.02 million
Cash Flow
C$0.33 per share
Book Value
C$0.40 per share

Miscellaneous

Free Float
N/A
Market Cap
C$52.28 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Avtar S. Dhillon (Age 59)
    Exec. Chairman
    Comp: $485.05k
  • Mr. Riaz Bandali M.B.A. (Age 51)
    CEO & Pres
    Comp: $428.21k
  • Ms. Jenn Hepburn B.B.A.
    CFO & Company Sec.
  • Mr. Orville Bovenschen
    Sr. VP of Operations
  • Mr. Bernie Hertel
    VP of Fin. and Communications
  • Ms. Rebecca Wong
    Sr. VP of Quality & Regulatory Affairs

EMH Stock Analysis - Frequently Asked Questions

How have EMH shares performed in 2024?

Emerald Health Therapeutics' stock was trading at C$0.26 on January 1st, 2024. Since then, EMH stock has increased by 0.0% and is now trading at C$0.26.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), Organigram (OGI), Emerald Health Therapeutics (EMHTF).

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:EMH) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners